At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,986 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Observational Serial Chart Review of Repatha® Use in European Subjects With Hyperlipidaemia
In Brief
An observational study for Hypercholesterolaemia. Completed, enrolled 1,986 participants across 183 sites in 12 countries.
Detailed Summary
Review of clinical characteristics of patients who are prescribed Repatha® and how their treatment is managed.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypercholesterolaemia
CountriesAustria, Belgium, Bulgaria, Czechia, Germany, Greece, Italy, Portugal, Slovakia, Spain, Sweden, Switzerland
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartMay 2016
First PostedMay 2016
Primary CompletionJun 2021
TodayJul 2026
First PostedMay 12, 2016
Enrollment StartMay 4, 2016
Primary CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 10.1 years ago